Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.41 |
| ▸ | CA1 | P00915 | 5/20 | 0.41 |
| ▸ | CA9 | Q16790 | 5/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | WDR5 | P61964 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | CCR9 | P51686 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6129791 | 0.84 | CA2 (0.40) | CA2CA1CA9CA5APTGS1 | |
| SCHEMBL6850641 | 0.84 | CA2 (0.40) | CA2CA1CA9CA5APTGS1 | |
| Lithium Ion SCHEMBL6856332 | 0.82 | CA2 (0.39) | CA2CA1CA9CA5APTGS1 | |
| SCHEMBL14184917 | 0.77 | CA1 (0.42) | CA2CA1CA9CA5APTGS1 | |
| SCHEMBL7871262 | 0.77 | ALOX15 (0.39) | CA2CA1CA9CA5APTGS1 | |
| SCHEMBL6854191 | 0.77 | PTGS1 (0.44) | CA2CA1CA9CA5APTGS1 | |
| SCHEMBL4323037 | 0.76 | CYP2A6 (0.38) | CA2CA1CA9CA5AKIF11 | |
| SCHEMBL1230294 | 0.76 | CYP2A6 (0.38) | CA2CA1CA9CA5AKIF11 | |
| SCHEMBL11716929 | 0.74 | MAPT (0.37) | CA2CA1CA9CA5AKIF11 | |
| SCHEMBL4617903 | 0.73 | KIF11 (0.45) | CA2CA1CA9CA5APTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008060735-A1 | MONOMERS COMPRISING SUPERACIDIC GROUPS, AND POLYMERS THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2008-05-22 | — | — | WO | disclosed |
| WO-2008060736-A1 | POLYMERS COMPRISING SUPERACIDIC GROUPS, AND USES THEREOF | GENERAL ELECTRIC COMPANY (US) | 2008-05-22 | — | — | WO | disclosed |
| US-20080114183-A1 | Monomers comprising superacidic groups, and polymers therefrom | GENERAL ELECTRIC COMPANY (US) | 2008-05-15 | — | — | US | disclosed |
| US-20080114149-A1 | Polymers comprising superacidic groups, and uses thereof | GENERAL ELECTRIC COMPANY (US) | 2008-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080114183-A1 | Monomers comprising superacidic groups, and polymers therefrom | DDC, ACMSD, ALKBH3 | CA2 82/4885CA1 298/4885CA9 941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.